K941220

Substantially Equivalent

DUPONT ACA PLUS PROLACTIN (PROL) METHOD

Applicant: Dupont Medical Products
Product code: CFT
Advisory panel: Clinical Chemistry
Date received: 1994-03-14
Decision date: 1994-06-03
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Wilmington, DE, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.